Immune Response Of Broilers Treated With Amprolium And Chloramphenicol
By: Rakhshanda Perveen Cheema | Dr. Muhammad Akram Muneer.
Contributor(s): Dr. Haji Ahmad | Dr. Muhammad Naeem | Faculty of Veterinary Sciences.
Material type: BookPublisher: 1994Subject(s): Department of MicrobiologyDDC classification: 0460,T Dissertation note: The birds that received arnprolium at recommended dosage levels had higher mean body weight than the chioramphenicol medicated, cyclophosphamide treated or untreated control birds. Arnprolium treatment did not adversely affect the weight of bursa of Fabricius, spleen, thymus and liver of birds. Chioramphenicol treatment slightly depressed the weight of bursa of Fabricius and thymus. Cyclophosphamide treatment of birds in early life resulted in bursal atrophy and slight depression of splenic weight. As compared to Cyclophosphamide treated and non-rnedicated control birds, the sera of NDV vaccinated birds fed Amprolium had higher antibody titres on day 42. The sera of chioramphenicol treated NDV vaccinated birds had lower antibody titres as compared to non-medicated control birds on day 42. The post-challenge sera of NDV vaccinated birds fed Amprolium also had higher antibody titre as compared to NDV vaccinated cyclophosphamide and chioramphenicol treated birds. The NDV vaccinated chioramphenicol treated and NDV vaccinated cyclophosphamide treated had high post NDV challenge mortality and the NDV vaccinated birds on amproliurn medicated rations and those on non-medicated rations did not have any significant post NDV challenge mortality.Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|---|---|
Thesis | UVAS Library Thesis Section | Veterinary Science | 0460,T (Browse shelf) | Available | 0460,T |
Browsing UVAS Library Shelves , Shelving location: Thesis Section , Collection code: Veterinary Science Close shelf browser
The birds that received arnprolium at recommended dosage levels had higher mean body weight than the chioramphenicol medicated, cyclophosphamide treated or untreated control birds.
Arnprolium treatment did not adversely affect the weight of bursa of Fabricius, spleen, thymus and liver of birds. Chioramphenicol treatment slightly depressed the weight of bursa of Fabricius and thymus. Cyclophosphamide treatment of birds in early life resulted in bursal atrophy and slight depression of splenic weight.
As compared to Cyclophosphamide treated and non-rnedicated control birds, the sera of NDV vaccinated birds fed Amprolium had higher antibody titres on day 42. The sera of chioramphenicol treated NDV vaccinated birds had lower antibody titres as compared to non-medicated control birds on day 42. The post-challenge sera of NDV vaccinated birds fed Amprolium also had higher antibody titre as compared to NDV vaccinated cyclophosphamide and chioramphenicol treated birds. The NDV vaccinated chioramphenicol treated and NDV vaccinated cyclophosphamide treated had high post NDV challenge mortality and the NDV vaccinated birds on amproliurn medicated rations and those on non-medicated rations did not have any significant post NDV challenge mortality.
There are no comments for this item.